For patients with intraductal carcinoma of the prostate (IDC-P), prostate-specific membrane antigen positron emission tomography (PSMA PET) may not show intraprostatic uptake — even in high-grade ...
Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal ...
Ductal adenocarcinoma of the prostate is a rare, yet aggressive, subtype of prostate cancer that diverges in clinicopathological and genomic characteristics from the more common acinar adenocarcinoma.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback